CAT-8015: A Second-generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22 -Expressing Hematological Malignancies

od Alderson, Ralph F., Kreitman, Robert J., Chen, Tianling, Yeung, Peter, Herbst, Ronald, Fox, Judy A., Pastan, Ira
Izdano 2009

Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma

od Tong, Wei-Gang, Chen, Rong, Plunkett, William, Siegel, David, Sinha, Rajni, Harvey, R. Donald, Badros, Ashraf Z., Popplewell, Leslie, Coutre, Steven, Fox, Judith A., Mahadocon, Kristi, Chen, Tianling, Kegley, Peggy, Hoch, Ute, Wierda, William G.
izdano v J Clin Oncol (2010)

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

od Lancet, Jeffrey E., Roboz, Gail J., Cripe, Larry D., Michelson, Glenn C., Fox, Judith A., Leavitt, Richard D., Chen, Tianling, Hawtin, Rachael, Craig, Adam R., Ravandi, Farhad, Maris, Michael B., Stuart, Robert K., Karp, Judith E.
izdano v Haematologica (2015)